Fortive (FTV)
(Delayed Data from NYSE)
$73.39 USD
+0.96 (1.33%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $73.39 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
FTV 73.39 +0.96(1.33%)
Will FTV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FTV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FTV
Fortive (FTV) Up 3.5% Since Last Earnings Report: Can It Continue?
Fortive (FTV) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
FTV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fortive (FTV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Fortive (FTV) Surpasses Q2 Earnings Estimates
Here's How Fortive (FTV) Is Placed Ahead of Q2 Earnings
Other News for FTV
Least shorted S&P 500 stocks in July
Short interest on S&P 500 Industrial dips after rising for five months
Short interest on S&P 500 Industrials dips after rising for five months
Citi spotlights 33 stocks in what it calls its ‘post pullback shopping list’
Advanced Sterilization Products Announces FDA Clearance for Revolutionary Sterilization Cycle for Duodenoscopes in Partnership with PENTAX Medical